Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems...

64
Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th - 11th 2013, St. Petersburg, RUSSIA

Transcript of Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems...

Page 1: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Building virtual cell using BioUML platform

Fedor Kolpakov

Biosoft.Ru, Ltd.Institute of Systems Biology, Ltd.

Novosibirsk, Russia

Biosoft.Ru

July 6th - 11th 2013, St. Petersburg, RUSSIA

Page 2: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

BioUML platform• BioUML is an open source integrated platform for systems biology

that spans the comprehensive range of capabilities including access to databases with experimental data, tools for formalized description, visual modeling and analyses of complex biological systems.

• Due to scripts (R, JavaScript) and workflow support it provides powerful possibilities for analyses of high-throughput data.

• Plug-in based architecture (Eclipse run time from IBM is used) allows to add new functionality using plug-ins.

BioUML platform consists from 3 parts: • BioUML server – provides access to biological databases;• BioUML workbench – standalone application. • BioUML web edition – web interface based on AJAX technology;

Page 3: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

BioUML main features• Supports access to main biological databases:

– catalolgs: Ensembl, UniProt, ChEBI, GO…– pathways: KEGG, Reactome, EHMN, BioModels, SABIO-RK,

TRANSPATH, EndoNet, BMOND…• Supports main standards used in systems biology:

SBML, SBGN, CellML, BioPAX, OBO, PSI-MI…• database search:

– full text search using Lucene engine– graph search

• graph layout engine• visual modeling:

– simulation engine supports (ODE, DAE, hybrid, stochastic, 1D PDE);– composite models;– agent based modeling, rule based modelling;– parameters fitting;

• genome browser (supports DAS protocol, tracks import/export);• data analyses and workflows – specialized plug-ins for microarray

analysis, integration with R/Bioconductor, JavaScript support, interactive script console.

Page 4: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Story 1:genome-scale model for prediction of synthesis rates of mRNAs and proteins

Initial data:Schwanhäusser B, Busse D, Li N, Dittmar G, Schuchhardt J,

Wolf J, Chen W, Selbach M. Global quantification of mammalian gene expression control. Nature, 2011, 473(7347):337-342.

- mouse fibroblasts, parallel metabolic pulse labelling- simultaneously measured absolute mRNA and protein

abundance and turnover for 5000+ genes- first genome-scale quantitative model for prediction of

synthesis rates of mRNAs and proteins

Bukharov Aleksandr, Kiselev Ilya

Page 5: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Experiment design

Page 6: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.
Page 7: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Schwanhäusser B., et al., 20011 - Fig. 6:bComparison of synthesis rates of mRNA and proteins assuming the measured levels reflect averages over one cell cycle or steady-state values. For the synthesis rates of mRNA (light gray), the deviation between the two approaches is small, because mRNA half lives are mostly smaller than the cell cycle time. For protein synthesis (dark gray), the differences are substantial; they can differ for more than one order of magnitude.

Page 8: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Schwanhäusser B., et al., 20011 - Fig. 6:bComparison of synthesis rates of mRNA and proteins assuming the measured levels reflect averages over one cell cycle or steady-state values. For the synthesis rates of mRNA (light gray), the deviation between the two approaches is small, because mRNA half lives are mostly smaller than the cell cycle time. For protein synthesis (dark gray), the differences are substantial; they can differ for more than one order of magnitude.

P – protein, exp – population mean,ss – steady state;

Page 9: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

“They do not take into account that gene expression in mammalian cells is non-continuous. In addition, the non-uniform age distribution of cells in culture as described in 19, 23 is neglected, since this effect is expected to be small compared to the deviation obtained by neglecting the cell cycle.“

Schwanhäusser B., et al., 20011, supplementary materials

Page 10: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Agent based model

each cell is an agent

4247 blocks for protein synthesis

Page 11: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Phase of a cellular cycle Percent of cells in phase

Rate of transcription

G1 50.8% Vsr

S 22.9% 0.7*Vsr G2 13% 2*Vsr M 3.3% 0 G0 10% Vsr

Tab.1. Parameters of a cellular cycle

Numerical experiment.

The initial size of population is 200 cells which divide within 108 hours. Average quantity of protein molecules were calculated. This experiment was repeated for 4247 proteins.

Page 12: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Correlation of experiment and numerical modeling is equal to R=0.99

Absolute values also were coordinated (so for 81,6% of proteins absolute values differ by less than 7%

Main deviations from experimental values are observed for proteins with extremely low copy numbers, where experimental error can be significant.

Page 13: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Used features of BioUML platform

• tables support (import, calculated columns);

• JavaScript API for model generation (from tabular data)

• visual modeling – diagram visualization

• agent based modeling

• ODE solver

Page 14: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

- tabIe with initial data (Schwannhauser B.et al., 2011);- calculated columns (k degradation)

Page 15: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Java script for diagram generation

Page 16: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Agent-based model

Page 17: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Story 2: the modular model of apoptosis

Kutumova E.O. et. al., Advances in Experimental Medicine and Biology, 2012, 736(2):235-245

13 modules279 species372

reactions 459

parameters

Page 18: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Modules: clear specification of interfaces

input/output

contacts

Page 19: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Mitochondron module(BMOND ID: Int_Mitoch_module)

Bagci EZ, et al, Biophysical J 2006Albeck JG, et al, PLoS Biol 2008Additions:Activation of CREB and deactivation of BAD by Akt-PP and ERK-PPUpregulation of Bcl-2 by CREBBcl-2 suppression by p53

Page 20: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

EGF module(BMOND ID: Int_EGF_module)

Schoeberl B, et al: Nature Biotechnology 2002

Borisov N, et al: Molecular Systems Biology 2009Additions:Reactions of protein syntheses and degradations

Page 21: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

top-down

Modular model allows us to combine both up-down and bottom-up approaches

bottom-up

Page 22: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Extreme programming (XP) Extreme programming (XP) methodologymethodology

•Planning– User stories– Make frequent small releases– The project is divided into iterations

•Coding– Code must be written to agreed standards– Unit test first– Integrate often – Collective ownership

•Testing– Unit/acceptance tests

Page 23: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

XP adaptation to modelingXP adaptation to modeling• Planning

– User stories: requirements for the model based on the experimental data

– Make frequent small releases– Iterations: after each iteration a new set of

experimental data should be reproduced• Coding

– Standards: SBGN, SBML, modular extension– Unit test first– Integrate often: model is saved into public

database– Collective ownership: collaborative editing

and chat• Testing

– Unit/acceptance tests: BioUML provides the facilities for testing the models.

Page 24: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Execution phase of Execution phase of apoptosisapoptosis

Page 25: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

User stories: requirements for the User stories: requirements for the modelmodel

• No external signals concentration of the cleaved PARP is zero.

• CD95L signaling dynamics of pro-8 and casp-8 according to Bentele et. al.

• TNF-a signaling dynamics of pro-8 and casp-8 according to Janes et. al.

Iteration 1

Iteration 2

Iteration 3

Page 26: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Types of the acceptance Types of the acceptance teststests

•Steady-state

•Time course

•Control of the variable values

Page 27: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Iterations and acceptance Iterations and acceptance teststests

Iteration 1Iteration 2

Iteration 3

Page 28: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Modeling of the execution phase of Modeling of the execution phase of apoptosisapoptosis

Bentele et. al., 2004

Page 29: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Iteration 1: execution phaseIteration 1: execution phase

Steady-state acceptance test

Page 30: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Iteration 2: CD95-signalingIteration 2: CD95-signaling

Page 31: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Iteration 2: CD95-signalingIteration 2: CD95-signaling

Experiment time courses for pro-8 and casp-8 according to the data by Bentele, et. al., 2004

Page 32: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Used features of BioUML platform

• visual modeling (SBGN notation)

• modular modelling

• parameters fitting

• acceptance tests

• ODE solver

Page 33: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Parameters fitting – user interface

Page 34: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Parameters fitting - main features• Experimental data – time courses or steady

states expressed as exact or relative values of substance concentrations

• Different optimization methods for analysis• Multi-experimentsfitting• Constraint optimization• Local/global parameters• Parameters optimization using java script

Page 35: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Bentele M, 2004

Neumann L, 2010

CD95L module and results of fitting its dynamics to

experimental data

Page 36: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Story 3Predicting transcription level from ChIP-seq data

Ivan Yevshin, Dmitry Levanov, Yuriy Kondrakhin

Page 37: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Initial row data, collected from literature, GEO, SRA and ENCODE databases were systematically collected and uniformly processed using specially developed workflow (pipeline) for BioUML platform:- sequenced reads were aligned to reference genome using Bowtie;- peaks were identified using MACS and SISSR algorithms- further refinement of obtained peaks- position weight matrices (PWM) were constructed by different methods(ChIPMunk, our own methods)- ROC curves were calculated to estimate and compare built PWM- site models (PWMs + thresholds) were constucted for recognition TFbinding sites.

TFClass database is used as a core for information about transcription factors, their classification and cross-linking with Ensembl.

BioUML platform provides web interface for access to GTRD database: search information, browsing, different data views. Built-in genomebrowser provides powerful visualisation of ChIP-seq data.

GTRD - Gene Transcription Regulation Database

Page 38: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.
Page 39: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.
Page 40: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Prediction of gene expression level by ChIP-seq dataChIP-seq peaks (MACS) for histones and transcriptio factor binding sites were extracted from GTRD database for 2 cell lines: GM12878 and K562.

Machine learning - Random Forest algorithm.

R - 0.72 – 0.77

Page 41: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Used features of BioUML platform• integration with Galaxy

to use 3-rd party command line tools (Bowtie, SISSR)• integration with R

for statistic analyses and plot visulisations• build-in analyses methods

NGS data control• workflows

for automated NGS data processing• genome browser

for ChIP-seq peaks visualisation• web interface for GTRD

– search possibilities– tree views– tables

Page 42: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Galaxy – analyses methods

Page 43: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Galaxy - workflow

Page 44: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

An example: workflow for analyses of ChIP-Seq data

Page 45: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.
Page 46: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Genome browser

Two BAM tracks are compared with each other (Example view on Human NCBI37 Chr.1)Profile is visible showing the coverage

Page 47: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Genome browser

Upon zooming individual reads become visible. All information associated with selected read is displayed in the Info box

Page 48: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Genome browser

In detailed scale phred qualities graph is displayed along with changed nucleotides between read and reference sequence

Page 49: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Story 4Glicomics – rule based modeling

Nikita Mandrik, Tagir Valeev

Rule-based modeling involves the representation of molecules as structured objects and molecular interactions as rules for transforming the attributes of these objects.

Data and approach:

Bennun SV, Yarema KJ, Betenbaugh MJ, Krambeck FJ. Integration of the transcriptome and glycome for identification of glycan cell signatures.

PLoS Comput Biol. 2013;9(1):e1002813. doi: 10.1371/journal.pcbi.1002813.

BioNetGen – language and approach for rule based modeling

http://bionetgen.org

Page 50: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Bennun S.V. et al., 2013

Page 51: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Bennun S.V. et al., 2013

Page 52: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.
Page 53: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.
Page 54: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Used features of BioUML platform• visual modeling• BioNetGen support (passed 8 available tests)• synchrinisation between model code and diagram• parameters fitting

Page 55: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Collaborative research goals• Allow scientists to effectively work together even if they

are separated far away from each other• Help experimentalists and theorists to work together• Engage third-party experts

Page 56: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Collaborative research1. Share

– Project data can be shared between several people– Changes are immediately visible by other participants– No need to ask administrator or somebody else to share the project

2. Communicate– Talk to each other in messenger– Conference chat

3. Collaborate– Edit together– Edit and chat– Review the changes of other participants

4. History– Monitor changes performed on the document– Rollback to older versions of the document– Compare different versions of the document– Project journal

5. Organize work (planned)– Create tasks (“works”) for other participants– Call for collaborators to solve particular problem– Review the results

6. Privacy– Your activity and data is invisible for people not belonging to your projects

Page 57: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

BioStorehttp://bio-store.org/

• BioStore is aimed to be the single place where researchers can register and obtain various products and services (either free or commercial).

• Having single BioStore account you may have an access to many BioUML servers, projects, downloads, etc.

Servers

DownloadsServices

Software

Page 58: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Biostore

BioUML platform

Developers- plug-ins: methods, visualization, etc.- databases

Users- subscriptions- collaborative & reproducible research

Experts-services for data analysis- on-line consultations

BioUML ecosystem

provide toolsand databases

use provide services

Page 59: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Challenges:

– methodology - how we can build, modify, verify and apply complex mathematical models for practical purposes;

– organization - how we can split main tasks into smaller, manageable parts and organize collaboration between researchers;

– software - we need a software platform that will provide necessary infrastructure for collaborative work of many researchers and will support needed methodology.

Building virtual cell

Page 60: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

Answers:

– methodology– modular modeling;– application of some practices from XP (eXtreme Programming):

– user stories, – iterative development, – acceptance tests;

– organization – Biostore - portal for collaborative research and crowd sourcing;

– software - BioUML platform - integrated open source platform for collaborative research in systems biology.

Building virtual cell

Page 61: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

www.biouml.org

Page 62: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.
Page 63: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.
Page 64: Building virtual cell using BioUML platform Fedor Kolpakov Biosoft.Ru, Ltd. Institute of Systems Biology, Ltd. Novosibirsk, Russia Biosoft.Ru July 6th.

BioUML teamTagir Valeev Ivan Yevshin

Yuriy KondrakhinIlya Kiselev Dmitriy LevanovElena Kutumova Alexandr Bukharov Ruslan SharipovNikita Mandrik